Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study
Authors
Keywords
-
Journal
Journal of the International AIDS Society
Volume 22, Issue 7, Pages -
Publisher
Wiley
Online
2019-07-12
DOI
10.1002/jia2.25338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand
- (2018) Pich Seekaew et al. PLoS One
- Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya
- (2015) Catherine S. Todd et al. CONTRACEPTION
- Pregnancy and Contraceptive Use Among Women Participating in the FEM-PrEP Trial
- (2015) Rebecca Callahan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV risk and preventive interventions in transgender women sex workers
- (2015) Tonia Poteat et al. LANCET
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
- (2015) Madeline B Deutsch et al. Lancet HIV
- Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception
- (2014) Pamela M. Murnane et al. AIDS
- Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception
- (2014) Renee Heffron et al. AIDS
- HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
- (2014) Deborah Donnell et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treating a Transgender Patient: Overview of the Guidelines
- (2014) Cory Wilczynski et al. POSTGRADUATE MEDICINE
- The Development of Sex Reassignment Surgery in Thailand: A Social Perspective
- (2014) Prayuth Chokrungvaranont et al. TheScientificWorldJOURNAL
- Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
- (2014) Olubanke Davies et al. Journal of the International AIDS Society
- Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)
- (2013) Louis J Gooren et al. ASIAN JOURNAL OF ANDROLOGY
- Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
- (2013) Kachit Choopanya et al. LANCET
- Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand
- (2013) Daniel Yang et al. PLoS One
- HIV surveillance and prevention in transgender women
- (2012) Frits van Griensven et al. LANCET INFECTIOUS DISEASES
- Worldwide burden of HIV in transgender women: a systematic review and meta-analysis
- (2012) Stefan D Baral et al. LANCET INFECTIOUS DISEASES
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
- (2012) Michael C. Thigpen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of Effect of Tenofovir Disoproxil Fumarate on Pharmacokinetics of Hormonal Contraceptives
- (2009) Brian P Kearney et al. PHARMACOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started